Ironwood Capital

Type

Private equity, Venture Debt

Location

Avon, United States

Total investments

34

Average round size

4M

Portfolio companies

28

Rounds per year

0.89

Lead investments

5

Follow on index

0.18

Exits

9

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologySoftwareFinTechInformation TechnologyPaymentsHealth CareManufacturingMedical DeviceCloud ComputingTherapeutics

Summary

In 1985 was created Ironwood Capital, which is appeared as VC. The main department of described VC is located in the Avon. The company was established in North America in United States.

The current fund was established by Carolyn Galiette, Hiran Embuldeniya, Marc Reich. Besides them, we counted 13 critical employees of this fund in our database.

Opposing the other organizations, this Ironwood Capital works on 7 percentage points less the average amount of lead investments. The high activity for fund was in 2019. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2016. The real fund results show that this VC is 2 percentage points more often commits exit comparing to other companies.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Ironwood Capital, startups are often financed by North Atlantic Capital, Mosaik Partners, Black Dragon Capital. The meaningful sponsors for the fund in investment in the same round are Connecticut Innovations, Advantage Capital, Spring Mountain Capital. In the next rounds fund is usually obtained by Connecticut Innovations, Mosaik Partners, Black Dragon Capital.

The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. We can highlight the next thriving fund investment areas, such as Health Care, Therapeutics. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Precipio Diagnostics, NovaTract Surgical, LiveClips.

Show more

Investor highlights

Industry generalist
Yes
Industry focus
GeneralistManufacturingB2B/EnterpriseHealthcareLogistics Show 3 more
Geo focus
United States
Check size
10M — 40M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 500000000
Fund raised date
2022-06-01

Analytics

Total investments
34
Lead investments
5
Exits
9
Rounds per year
0.89
Follow on index
0.18
Investments by industry
  • Biotechnology (10)
  • Health Care (7)
  • Software (5)
  • Therapeutics (5)
  • Medical Device (4)
  • Show 44 more
Investments by region
  • United States (34)
Peak activity year
2017

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
28
Group Appearance index
0.74
Avg. company exit year
23

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Floop 16 Mar 2011 Mobile Apps, Social Network, Real Time, Social Media Seed 150K United States, Connecticut
Modifi Bio 16 Oct 2023 Biotechnology, Medical, Therapeutics Seed 4M United States, Connecticut, New Haven
RealtyMogul 01 Oct 2012 Real Estate, Financial Services, Finance, Marketplace, Real Estate Investment Seed United States, California, Los Angeles

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.